This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
The Food and Drug Administration issued an update to Aduhelm’s label, now requiring a total of four MRIs during the first year of treatment…
Biogen has withdrawn the application anti-amyloid Alzheimer’s drug Aduhelm from Europe’s regulatory agency. Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s…
Scientists are exploring the role of tau tangles in Alzheimer’s, and whether addressing these misfolded proteins could treat the disease. Here’s what you need…
The brain’s power generators, mitochondria, could hold the key to Alzheimer’s. Despite accounting for just two percent of our body weight, the brain consumes…
A new study explores the cognitive benefits of piano lessons in older adults. Researchers have long been studying the therapeutic benefits of listening to…
Could the bacteria that causes gum disease also trigger Alzheimer’s? A drug candidate targeting this bacteria recently failed its early trials, but some experts…